120 related articles for article (PubMed ID: 1773360)
1. In vivo inhibition of megakaryocyte and platelet production by platelet factor 4 in mice.
Han ZC; Bellucci S; Bodevin E; Wan HY; Shen ZX; Caen JP
C R Acad Sci III; 1991; 313(12):553-8. PubMed ID: 1773360
[TBL] [Abstract][Full Text] [Related]
2. In vivo effects of pegylated recombinant human megakaryocyte growth and development factor on hematopoiesis in normal mice.
Kabaya K; Akahori H; Shibuya K; Nitta Y; Ida M; Kusaka M; Kato T; Miyazaki H
Stem Cells; 1996 Nov; 14(6):651-60. PubMed ID: 8948023
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
Cardier JE; Erickson-Miller CL; Murphy MJ
Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
[TBL] [Abstract][Full Text] [Related]
4. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice.
Chow FP; Zsebo K; Hamburger AW
Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220
[TBL] [Abstract][Full Text] [Related]
5. The humoral regulation of megakaryocytopoiesis and platelet production in vivo.
Kuriya S; Murphy MJ
Blood Cells; 1986; 12(1):233-47. PubMed ID: 3491644
[TBL] [Abstract][Full Text] [Related]
6. Megakaryocytopoiesis and granulopoiesis in W/Wv mice: comparisons between bone marrow and spleen.
Petursson SR; Chervenick PA
J Lab Clin Med; 1987 Dec; 110(6):773-83. PubMed ID: 3681118
[TBL] [Abstract][Full Text] [Related]
7. [Platelet factor 4, reversible inhibitor of megakaryocytogenesis, protector of megakaryocytes during chemotherapy].
Caen JP; Xi X; Aidoudi S; Fournier S; Schlegel N; Bellucci S; Han ZC
Bull Acad Natl Med; 1995 Nov; 179(8):1657-70. PubMed ID: 8717183
[TBL] [Abstract][Full Text] [Related]
8. Continuous infusion of interleukin-6 in sublethally irradiated mice accelerates platelet reconstitution and the recovery of myeloid but not of megakaryocytic progenitor cells in bone marrow.
Laterveer L; van Damme J; Willemze R; Fibbe WE
Exp Hematol; 1993 Dec; 21(13):1621-7. PubMed ID: 8243564
[TBL] [Abstract][Full Text] [Related]
9. Physiologic role of TPO in thrombopoiesis.
Miyazaki H
Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
[TBL] [Abstract][Full Text] [Related]
10. [Platelet factor 4 acts as both inhibitor and protector of hematopoietic precursor cells: possible mechanism of action].
Han ZC; Zhang XJ; Xi XD; Lu M; Jiang S; Jiang LZ; Wang XM; Gu GL; Caen JP
Shi Yan Sheng Wu Xue Bao; 1995 Dec; 28(4):415-26. PubMed ID: 8731973
[TBL] [Abstract][Full Text] [Related]
11. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
Chen TW; Hwang SM; Chu IM; Hsu SC; Hsieh TB; Yao CL
Exp Hematol; 2009 Nov; 37(11):1330-1339.e5. PubMed ID: 19664680
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of the formation of pure and heterogeneous megakaryocyte colonies by megakaryocyte progenitor cells in vitro.
Lieschke GJ
Exp Hematol; 1982 Jan; 10(1):78-89. PubMed ID: 6977456
[TBL] [Abstract][Full Text] [Related]
13. The effects of 5-fluorouracil on hematopoiesis: studies of murine megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels.
Yeager AM; Levin J; Levin FC
Exp Hematol; 1983 Nov; 11(10):944-52. PubMed ID: 6662215
[TBL] [Abstract][Full Text] [Related]
14. Lithium and hematopoietic toxicity. II. Acceleration in vivo of murine hematopoietic progenitor cells (CFU-gm and CFU-meg) following treatment with vinblastine sulfate.
Gallicchio VS
Int J Cell Cloning; 1987 Mar; 5(2):122-33. PubMed ID: 3572050
[TBL] [Abstract][Full Text] [Related]
15. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
16. NF-E2-mediated enhancement of megakaryocytic differentiation and platelet production in vitro and in vivo.
Fock EL; Yan F; Pan S; Chong BH
Exp Hematol; 2008 Jan; 36(1):78-92. PubMed ID: 17923245
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of megakaryocytopoiesis in mice by human modified C-reactive protein (mCRP).
Potempa LA; Motie M; Wright KE; Crump BL; Radosevich JA; Sakai N; Lai G; Tanaka K; Kojima E; Tsuboi A
Exp Hematol; 1996 Feb; 24(2):258-64. PubMed ID: 8641350
[TBL] [Abstract][Full Text] [Related]
18. Compensatory mechanisms in platelet production: lack of a paracrine response in W/Wv mice treated with 5-fluorouracil.
Arnold JT; Radley JM; Williams NT
Exp Hematol; 1993 Mar; 21(3):414-9. PubMed ID: 8440339
[TBL] [Abstract][Full Text] [Related]
19. [The hemoprotective effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP].
Han Z; Cai Y; Aidoudi S
Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):33-5. PubMed ID: 11498842
[TBL] [Abstract][Full Text] [Related]
20. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
Gallicchio VS; Hughes NK; Tse KF
Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
